Page last updated: 2024-08-17

levodopa and Neuroleptic Malignant Syndrome

levodopa has been researched along with Neuroleptic Malignant Syndrome in 70 studies

Research

Studies (70)

TimeframeStudies, this research(%)All Research%
pre-199012 (17.14)18.7374
1990's23 (32.86)18.2507
2000's21 (30.00)29.6817
2010's11 (15.71)24.3611
2020's3 (4.29)2.80

Authors

AuthorsStudies
Jiang, W; Li, R; Lin, Y; Ma, L; Zhang, N1
Bin, Q; Hantao, S; JiYi, X; Lijiao, Z1
Doherty, AM; Flood, J; O'Keeffe, S; Talty, M; Waqas, S1
Manjunath, MB; Ray, A; Sahu, H; Vikram, NK1
Casier, I; Hantson, P; Jeanjean, A1
Ando, Y; Sakamoto, M; Shindo, Y; Shinoda, M; Tateda, T1
Anticoli, S; De Pandis, MF; Fiore, S; Persichino, L1
Fukuda, K1
Madigan, EJ1
Bonanni, L; Cossu, G; Manca, D; Onofrj, M; Stocchi, F; Thomas, A1
McKeith, I1
Heinz, A; Majic, T; Mell, T; Rapp, MA1
Moreno-Salcedo, JM; Ramírez-Relinque, L; Romero, FJ; Santisteban-López, Y1
Bonnici, A; Hornstein, D; Ruiner, CE; St-Laurent, L1
Man, SP1
Birthi, P; McDowell, S; Perry, D; Salles, S1
Ichinose, H; Ihara, M; Ikeda, A; Kawamoto, Y; Kohara, N; Nishida, T; Saiki, H; Shibasaki, H; Takagi, S; Takao, S; Urano, F1
Reingardiene, D1
Agid, Y; Bejjani, BP; Houeto, JL; Mallet, L; Mesnage, V; Welter, ML1
Serrano-Dueñas, M1
Hillis, RE; Lee, DA1
Kuno, S; Mizuno, Y; Mizuta, E; Takubo, H1
Hanyu, N; Hashimoto, T; Tabata, K; Tokuda, T; Yanagisawa, N1
Mizuno, Y; Shimoda-Matsubayashi, S; Takubo, H1
Kaji, M; Metoki, N; Sato, Y; Satoh, K; Yoshida, H1
Adarraga Cansino, MD; Rosa Jiménez, F; Velasco Malagón, MJ; Zambrana García, JL1
Ladha, SS; Shill, HA; Walker, R1
Onofrj, M; Thomas, A1
Aydemir, T; Aydin, B; Hanoglu, L; Meral, H; Oral, T; Ozer, F1
Ward, C1
Herkes, GK; McKay, D; Meagher, LJ; Needham, M1
Tarsy, D1
Kuno, S; Mizuta, E; Nakatake, M; Yamasaki, S1
Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK1
Cape, G1
Hirai, S; Kondo, T; Mizuno, Y; Mori, H; Suda, K; Tanabe, K; Yokochi, F1
Kornhuber, J; Weller, M1
Kaufman, BS; Young, CC1
del Toro Cervera, J; García Castaño, J; Muiño Miguez, A; Segado Soriano, A1
Cernek, PK; Shoop, SA1
Ishiguro, T; Nisijima, K; Noguti, M1
Kobayashi, T; Muneta, S; Saeki, H1
Egi, N; Harada, T; Kumagai, R; Kurokawa, K; Nakamura, S; Okazaki, M; Shimote, K1
Sunohara, N1
Bonoma, RA; Iwuagwu, CU; Riley, D1
Chew, EL; Ong, KC; Ong, YY1
Susman, VL1
Frucht, SJ; Gordon, PH1
Ogawa, N; Yamawaki, Y2
Akai, M; Idemura, Y; Ishizaki, T; Matsubara, R; Miyaho, S; Nakaguki, K; Nakai, T; Sasaki, F; Uchiki, H1
Bonuccelli, U; Corsini, GU; Muratorio, A; Piccini, P1
Lefeber, EJ; Rainer, C; Scheinost, NA1
Altus, P; Hencey, MA; Weissman, MS1
Ito, H; Kikuchi, H; Noda, S; Yamamoto, A; Yamamoto, H1
Goldswain, PR; Harrison, WB; Reutens, DC1
Montastruc, JL; Rascol, O; Salachas, F1
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T1
Clarke, CE; Green, MH; Shand, D; Yuill, GM1
Gibb, WR1
Greenberg, HS; Hirschorn, KA1
Harris, M; Nora, L; Tanner, CM1
Lambrecht, ER; Meems, BJ1
Lazarus, A1
Iacono, RP; Sandyk, R1
Gibb, WR; Griffith, DN1
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G1
Feinberg, SS; Feldman, RG; Friedman, JH1
Genís, D1
Ezrielev, GZ1

Reviews

10 review(s) available for levodopa and Neuroleptic Malignant Syndrome

ArticleYear
Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.
    Parkinsonism & related disorders, 2009, Volume: 15 Suppl 3

    Topics: Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinsonian Disorders; Polyneuropathies

2009
[Neuroleptic malignant syndrome].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:1

    Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis

2002
Malignant syndrome in Parkinson's disease: concept and review of the literature.
    Parkinsonism & related disorders, 2003, Volume: 9 Suppl 1

    Topics: Antiparkinson Agents; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

2003
Movement disorders with neuroleptic drug treatment.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3

    Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Huntington Disease; Levodopa; Neuroleptic Malignant Syndrome; Parasympatholytics; Parkinson Disease, Secondary; Receptors, Dopamine; Time Factors; Tourette Syndrome

1984
[Toxic and adverse neurological effects of anti-parkinsonian drugs].
    Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders

1999
Clinical management of neuroleptic malignant syndrome.
    The Psychiatric quarterly, 2001,Winter, Volume: 72, Issue:4

    Topics: Bromocriptine; Carbidopa; Dopamine Agonists; Drug Combinations; Electroconvulsive Therapy; Guidelines as Topic; Humans; Levodopa; Neuroleptic Malignant Syndrome; Physical Therapy Specialty

2001
Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:11

    Topics: Aged; Antithrombins; Benzamidines; Dantrolene; Disseminated Intravascular Coagulation; Female; Guanidines; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease

1992
Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
    Postgraduate medicine, 1991, Volume: 89, Issue:5

    Topics: Aged; Carbidopa; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1991
[Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
    Rinsho shinkeigaku = Clinical neurology, 1991, Volume: 31, Issue:1

    Topics: Aged; Benzamidines; Dantrolene; Disseminated Intravascular Coagulation; Female; Guanidines; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease

1991
[Neuroleptic malignant-like syndrome following levodopa withdrawal].
    Revue neurologique, 1990, Volume: 146, Issue:3

    Topics: Aged; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1990

Other Studies

60 other study(ies) available for levodopa and Neuroleptic Malignant Syndrome

ArticleYear
Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases.
    BMC neurology, 2022, Feb-25, Volume: 22, Issue:1

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Humans; Levodopa; Multiple System Atrophy; Neuroleptic Malignant Syndrome

2022
Case report: cold medicines cause neuroleptic malignant-like syndrome in a patient with Parkinson's disease.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:7

    Topics: Antipsychotic Agents; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease

2022
There is more to this fever than meets the eye: A case of neuroleptic malignant-like syndrome (NMLS) secondary to withdrawal of procyclidine and L-dopa on a background of long-standing flupenthixol depot use.
    Irish journal of psychological medicine, 2023, Volume: 40, Issue:2

    Topics: Antipsychotic Agents; Flupenthixol; Humans; Levodopa; Neuroleptic Malignant Syndrome; Procyclidine

2023
Neuroleptic malignant-like syndrome causing thrombocytopaenia: a rare association.
    BMJ case reports, 2018, Dec-03, Volume: 11, Issue:1

    Topics: Diagnosis, Differential; Glasgow Coma Scale; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Patient Compliance; Thrombocytopenia

2018
Postoperative hyperthermic syndrome following antiparkinsonian drugs withdrawal: the pitfall of enteral refeeding.
    Anaesthesia and intensive care, 2013, Volume: 41, Issue:6

    Topics: Aged, 80 and over; Antiparkinson Agents; Diagnosis, Differential; Drug Administration Schedule; Drug Interactions; Enteral Nutrition; Follow-Up Studies; Humans; Intubation, Gastrointestinal; Levodopa; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome; Postoperative Period; Substance Withdrawal Syndrome

2013
[Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
    Masui. The Japanese journal of anesthesiology, 2013, Volume: 62, Issue:12

    Topics: Aged, 80 and over; Anesthesia; Aortic Aneurysm, Thoracic; Cardiac Surgical Procedures; Dantrolene; Extracorporeal Circulation; Female; Humans; Infusions, Intravenous; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Perioperative Care; Postoperative Complications

2013
A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report.
    Acta bio-medica : Atenei Parmensis, 2014, Dec-17, Volume: 85, Issue:3

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dopamine Agonists; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes

2014
Integrated theory to unify status among schizophrenia and manic depressive illness.
    Medical hypotheses, 2015, Volume: 85, Issue:4

    Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Biopterins; Bipolar Disorder; Blood-Brain Barrier; Depression; Depression, Postpartum; Dopamine; Female; Hallucinations; Humans; Kynurenic Acid; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurotransmitter Agents; Paranoid Disorders; Premenstrual Syndrome; Schizophrenia; Seasonal Affective Disorder; Serotonin; Serotonin Syndrome; Tyrosine

2015
A 77-year-old man with Parkinson's disease and hyperthermia.
    Journal of emergency nursing, 2008, Volume: 34, Issue:3

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Combined Modality Therapy; Emergency Service, Hospital; Emergency Treatment; Follow-Up Studies; Humans; Levodopa; Male; Malignant Hyperthermia; Neuroleptic Malignant Syndrome; Parkinson Disease; Pramipexole; Risk Assessment; Treatment Outcome

2008
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome: some comments.
    International psychogeriatrics, 2010, Volume: 22, Issue:4

    Topics: Antiparkinson Agents; Clozapine; Delusions; Drug Therapy, Combination; Humans; Levodopa; Lewy Body Disease; Movement Disorders; Neuroleptic Malignant Syndrome; Severity of Illness Index

2010
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome.
    International psychogeriatrics, 2010, Volume: 22, Issue:4

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Delusions; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Severity of Illness Index

2010
[Dopaminergic malignant syndrome due to acute withdrawal of l-dopa].
    Revista clinica espanola, 2010, Volume: 210, Issue:5

    Topics: Aged; Dopamine Agents; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome

2010
An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
    The Annals of pharmacotherapy, 2010, Volume: 44, Issue:9

    Topics: Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Enteral Nutrition; Food-Drug Interactions; Humans; Intensive Care Units; Length of Stay; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease

2010
An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2011, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dopamine Agonists; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome

2011
Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
    PM & R : the journal of injury, function, and rehabilitation, 2012, Volume: 4, Issue:5

    Topics: Carbidopa; Cerebral Palsy; Child; Dopamine Agents; Drug Therapy, Combination; Dystonia; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome

2012
Neuroleptic malignant syndrome with prolonged catatonia in a dopa-responsive dystonia patient.
    Neurology, 2002, Oct-08, Volume: 59, Issue:7

    Topics: Adult; Catatonia; Dystonia; Electroencephalography; Female; GTP Cyclohydrolase; Humans; Levodopa; Neuroleptic Malignant Syndrome

2002
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
    Neurology, 2003, Jan-14, Volume: 60, Issue:1

    Topics: Confusion; Depression; Dopamine Agonists; Electric Stimulation Therapy; Follow-Up Studies; Levodopa; Mood Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease; Quality of Life; Social Behavior Disorders; Substance Withdrawal Syndrome; Subthalamic Nucleus; Time; Treatment Outcome

2003
Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients.
    Parkinsonism & related disorders, 2003, Volume: 9, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Diagnosis, Differential; Female; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

2003
Viral encephalitis complicated by neuroleptic malignant syndrome in a 7-year-old girl.
    Pediatric emergency care, 2003, Volume: 19, Issue:2

    Topics: Anticonvulsants; Carbidopa; Child; Dopamine Agents; Drug Therapy, Combination; Encephalitis, Viral; Epilepsy, Tonic-Clonic; Female; Haloperidol; Humans; Hypnotics and Sedatives; Levodopa; Neuroleptic Malignant Syndrome; Psychomotor Agitation

2003
Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease.
    Parkinsonism & related disorders, 2003, Volume: 9 Suppl 1

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Dehydration; Female; Fever; Health Status; Humans; Incidence; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Risk Factors; Substance Withdrawal Syndrome

2003
Serum creatine kinase is elevated in patients with Parkinson's disease: a case controlled study.
    Parkinsonism & related disorders, 2003, Volume: 9 Suppl 1

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Creatine Kinase; Female; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

2003
Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents.
    Journal of the neurological sciences, 2003, Aug-15, Volume: 212, Issue:1-2

    Topics: Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antiparkinson Agents; Blood Coagulation Disorders; Case-Control Studies; Dopamine Agents; Drug Therapy, Combination; E-Selectin; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Humans; International Normalized Ratio; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Peptide Fragments; Prothrombin; Thrombomodulin

2003
[Malignant dopaminergic syndrome].
    Medicina clinica, 2004, Apr-03, Volume: 122, Issue:12

    Topics: Aged; Dopamine Agents; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease

2004
Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5

    Topics: Diagnosis, Differential; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Phytotherapy; Substance Withdrawal Syndrome; Vicia faba

2005
Acute akinesia in Parkinson disease.
    Neurology, 2005, Apr-12, Volume: 64, Issue:7

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Akinetic Mutism; Apomorphine; Body Temperature; Cohort Studies; Comorbidity; Dopamine Agents; Dose-Response Relationship, Drug; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Mortality; Neuroleptic Malignant Syndrome; Parkinson Disease; Prospective Studies; Recovery of Function; Treatment Failure

2005
Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome.
    The journal of ECT, 2005, Volume: 21, Issue:2

    Topics: Antiparkinson Agents; Dopamine Agents; Drug Administration Schedule; Electroconvulsive Therapy; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Psychoses, Substance-Induced

2005
Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2005, Volume: 37, Issue:3

    Topics: Aged; Antiparkinson Agents; Confusion; Dantrolene; Deep Brain Stimulation; Dehydration; Dopamine Agents; Drug Monitoring; Electrolytes; Fever; Humans; Leukocyte Count; Levodopa; Magnetic Resonance Imaging; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Nurse's Role; Nursing Assessment; Parkinson Disease; Physical Examination; Substance Withdrawal Syndrome; Time Factors; Urinalysis

2005
Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2006, Volume: 13, Issue:8

    Topics: Acetaminophen; Acyclovir; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiparkinson Agents; Antiviral Agents; Anxiety; Carbidopa; Ceftriaxone; Cervical Vertebrae; Depression; Dexamethasone; Diazepam; Doxepin; Electroconvulsive Therapy; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxycodone; Pain; Parkinson Disease; Selegiline; Spinal Injuries

2006
Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period.
    Neurology, 1993, Volume: 43, Issue:5

    Topics: Body Temperature; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Menstrual Cycle; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease

1993
Management of neuroleptic malignant syndrome--a series of eight cases.
    The Journal of the Association of Physicians of India, 1993, Volume: 41, Issue:2

    Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome

1993
Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
    The British journal of psychiatry : the journal of mental science, 1994, Volume: 164, Issue:1

    Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Antisocial Personality Disorder; Combined Modality Therapy; Critical Care; Dantrolene; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluphenazine; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizoid Personality Disorder; Sick Role; Social Environment; Substance Withdrawal Syndrome

1994
[A 75-year-old man with parkinsonism and delirium].
    No to shinkei = Brain and nerve, 1994, Volume: 46, Issue:1

    Topics: Aged; Delirium; Fever; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substantia Nigra

1994
Amantadine withdrawal and neuroleptic malignant syndrome.
    Neurology, 1993, Volume: 43, Issue:10

    Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1993
Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
    Journal of clinical anesthesia, 1995, Volume: 7, Issue:8

    Topics: Anesthesia; Antiparkinson Agents; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Neuromuscular Blocking Agents; Postoperative Complications; Substance Withdrawal Syndrome

1995
[Malignant-like neuroleptic syndrome: a sign to call attention to].
    Anales de medicina interna (Madrid, Spain : 1984), 1995, Volume: 12, Issue:9

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Cephalosporins; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease

1995
Carbidopa/levodopa in the treatment of neuroleptic malignant syndrome.
    The Annals of pharmacotherapy, 1997, Volume: 31, Issue:1

    Topics: Adult; Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome

1997
Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
    Biological psychiatry, 1997, Apr-15, Volume: 41, Issue:8

    Topics: Adult; Dantrolene; Dopamine Agents; Female; Humans; Injections, Intravenous; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Schizophrenia

1997
[Malignant syndrome associated with disseminated intravascular coagulation and a high level of amylase in serum, followed by diabetic coma in an elderly patient with Parkinson's disease during L-dopa therapy].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1998, Volume: 35, Issue:2

    Topics: Aged; Amylases; Diabetic Coma; Disseminated Intravascular Coagulation; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1998
[A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome].
    No to shinkei = Brain and nerve, 1998, Volume: 50, Issue:8

    Topics: Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Fludrocortisone; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Shy-Drager Syndrome

1998
Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
    The American journal of medicine, 2000, Apr-15, Volume: 108, Issue:6

    Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Confusion; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Nitrophenols; Substance Withdrawal Syndrome; Tolcapone

2000
Neuroleptic malignant syndrome without neuroleptics.
    Singapore medical journal, 2001, Volume: 42, Issue:2

    Topics: Antiparkinson Agents; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

2001
Neuroleptic malignant syndrome in advanced Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:5

    Topics: Adult; Antiparkinson Agents; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Secondary Prevention; Severity of Illness Index; Substance Withdrawal Syndrome

2001
[Autopsied case of Parkinson disease with neuroleptic malignant-like syndrome and rhabdomyolysis].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992, Nov-10, Volume: 81, Issue:11

    Topics: Acute Kidney Injury; Aged; Brain; Humans; Kidney; Levodopa; Male; Muscles; Neuroleptic Malignant Syndrome; Parkinson Disease; Rhabdomyolysis

1992
Apomorphine in malignant syndrome due to levodopa withdrawal.
    Italian journal of neurological sciences, 1992, Volume: 13, Issue:2

    Topics: Aged; Apomorphine; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1992
A 73-year-old woman with confusion, rigidity, and fever.
    Hospital practice (Office ed.), 1991, Jun-15, Volume: 26, Issue:6

    Topics: Aged; Carbidopa; Confusion; Drug Therapy, Combination; Female; Fever; Humans; Levodopa; Muscle Rigidity; Neuroleptic Malignant Syndrome; Parkinson Disease

1991
[Case of malignant syndrome suggesting a central hyperthermic mechanism].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Apr-10, Volume: 80, Issue:4

    Topics: Antidepressive Agents; Female; Fever; Humans; Hypothalamus; Levodopa; Middle Aged; Morpholines; Neuroleptic Malignant Syndrome

1991
Neuroleptic malignant syndrome complicating levodopa withdrawal.
    The Medical journal of Australia, 1991, Jul-01, Volume: 155, Issue:1

    Topics: Aged; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1991
Neuroleptic malignant syndrome without neuroleptics.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan

1990
Clinical spectrum of neuroleptic malignant syndrome.
    Lancet (London, England), 1988, Oct-22, Volume: 2, Issue:8617

    Topics: Adult; Drug Therapy, Combination; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Schizophrenia; Tranquilizing Agents

1988
Neuroleptic malignant syndrome in striatonigral degeneration.
    The British journal of psychiatry : the journal of mental science, 1988, Volume: 153

    Topics: Aged; Corpus Striatum; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Substantia Nigra

1988
Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
    Clinical neuropharmacology, 1988, Volume: 11, Issue:3

    Topics: Aged; Cyproheptadine; Humans; Levodopa; Male; Methysergide; Myoclonus; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1988
Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis.
    Clinical neuropharmacology, 1987, Volume: 10, Issue:2

    Topics: Adult; Carbidopa; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders

1987
A case of neuroleptic malignant syndrome with myoglobinuric acute renal failure treated with dialysis and levodopa.
    The Netherlands journal of medicine, 1987, Volume: 30, Issue:1-2

    Topics: Acute Kidney Injury; Adult; Combined Modality Therapy; Female; Humans; Levodopa; Myoglobinuria; Neuroleptic Malignant Syndrome; Renal Dialysis; Rhabdomyolysis

1987
Therapy of neuroleptic malignant syndrome.
    Psychiatric developments, 1986,Spring, Volume: 4, Issue:1

    Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine

1986
Levodopa withdrawal and the neuroleptic malignant syndrome.
    Postgraduate medical journal, 1986, Volume: 62, Issue:729

    Topics: Humans; Levodopa; Neuroleptic Malignant Syndrome; Substance Withdrawal Syndrome

1986
Levodopa withdrawal syndrome identical to neuroleptic malignant syndrome.
    Postgraduate medical journal, 1986, Volume: 62, Issue:723

    Topics: Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1986
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
    Neurology, 1985, Volume: 35, Issue:2

    Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine

1985
A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
    JAMA, 1985, Nov-15, Volume: 254, Issue:19

    Topics: Aged; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1985
Neuroleptic malignant syndrome: impaired dopaminergic systems?
    Neurology, 1985, Volume: 35, Issue:12

    Topics: Humans; Levodopa; Neuroleptic Malignant Syndrome

1985
[Acute dopamine deficiency and malignant neuroleptic-like syndrome].
    Harefuah, 1992, Apr-15, Volume: 122, Issue:8

    Topics: Antiparkinson Agents; Dopamine; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Organic Chemicals; Parkinson Disease

1992